Moderna (MRNA) Tops Q4 EPS by $1.54, Beats on Revenue, Reaffirms COVID-19 Vax Guidance
Go back to Moderna (MRNA) Tops Q4 EPS by $1.54, Beats on Revenue, Reaffirms COVID-19 Vax Guidance| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 173.20 +19.16 (12.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.04 | 52 Week High | $0.52 | |||
| Open | $161.05 | 52 Week Low | $0.08 | |||
| Day High | $176.86 | P/E | N/A | |||
| Day Low | $159.06 | EPS | $-3.80 | |||
| Volume | 17,182,740 | |||||
